Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 557 clinical trials
Postoperative Immunotherapy vs Standard Chemotherapy for Gastric Cancer With High Risk for Recurrence

The primary objective of the trial is to investigate if nivolumab plus ipilimumab given as adjuvant treatment improve disease free survival (DFS) in patients with stage Ib-IVa gastric and

  • 33 views
  • 10 Feb, 2021
  • 25 locations
Gemcitabine + Carboplatin + Nivolumab Versus Gemcitabine + Oxaliplatin + Nivolumab in Cisplatin-ineligible Patients With Metastatic Urothelial Cancer

This is a randomized phase 2 trial of gemcitabine + carboplatin + nivolumab or gemcitabine + oxaliplatin + nivolumab for the treatment of cisplatin-ineligible patients with metastatic urothelial

  • 4 views
  • 23 Jan, 2021
  • 4 locations
Nivolumab/Ipilimumab in Second Line CUP-syndrome

To compare the efficacy of nivolumab plus ipilimumab in subjects with high vs. Intermediate/low TMB poor-prognosis CUP (non-specific subset) who are relapsed or refractory to platinum-based

  • 0 views
  • 24 Jan, 2021
  • 1 location
  • 82 views
  • 28 Jan, 2021
  • 12 locations
Ipilimumab and Nivolumab as Adjuvant Treatment of Mucosal Melanoma

This is a single arm phase II clinical trial of Ipilimumab and Nivolumab in patients with resected mucosal melanoma. Ipilimumab (1 mg/kg) and Nivolumab (3 mg/kg) will be administered Day 1 of a

  • 49 views
  • 03 Mar, 2021
  • 6 locations
Dexamethasone Carfilzomib & Nivolumab With Pelareorep for Relapsed/Refractory Multiple Myeloma

This phase I trial studies the side effects and best dose of wild-type reovirus (pelareorep) when given together with dexamethasone, carfilzomib, and nivolumab in treating patients with multiple

proteasome inhibitor
monoclonal antibodies
refractory multiple myeloma
hysterectomy
bortezomib
  • 21 views
  • 28 Jan, 2021
  • 2 locations
Nivolumab Plus Relatlimab in Patients With Metastatic Uveal Melanoma

The purpose of this research is to test if a combination treatment of nivolumab and relatlimab will result in tumor reduction in patients with metastatic uveal melanoma.

  • 0 views
  • 27 Jan, 2021
  • 2 locations
Temozolomide Cisplatin and Nivolumab in People With Colorectal Cancer

This study will test whether the combination of cisplatin, nivolumab, and temozolomide is an effective treatment for in people with advanced and/or metastatic colorectal cancer that is mismatch

  • 0 views
  • 26 Jan, 2021
  • 7 locations
Adoptive Tumor-infiltrating Lymphocyte Transfer With Nivolumab for Melanoma

after non-myeloablative chemotherapy with cyclophosphamide and fludarabine. TIL transfer will be combined with low dose Interleukin (IL)-2 and nivolumab anti-PD-1 treatment. The study uses a

interleukin
hepatitis b antigen
metastatic melanoma
platelet count
cyclophosphamide
  • 0 views
  • 25 Jan, 2021
  • 1 location
Nivolumab and Ipilimumab in Classical Kaposi Sarcoma (CKS)

A Phase 2 study of nivolumab plus ipilimumab in previously treated classical Kaposi Sarcoma (CKS)

  • 0 views
  • 22 Jan, 2021
  • 1 location